HR 5187

0likes☆Favorite🔕SubscribeShare

Introduced ↻ Update bill dataRe-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click. Contact your reps Urge the sponsor

IN THE HOUSE OF REPRESENTATIVES

September 8, 2025

Mr. Khanna (for himself, Mr. Garamendi, and Mr. Davis of North Carolina) introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. BIOINDUSTRIAL COMMERCIALIZATION PROGRAM.

(a) In General.—Not later than one year after the date of the enactment of this Act, the Secretary of Defense may establish a program to support the expansion of the domestic capacity for bioindustrial manufacturing of critical biomanufactured products at a commercial level through awards to eligible entities for establishing, upgrading, and retooling of eligible bioindustrial manufacturing facilities.

(b) Awards.—

(1) In general.—An entity seeking an award under the program shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary determines appropriate.

(2) Competitive awards.—The Secretary shall make each award under the program to an eligible entity in a competitive manner.

(3) Award criteria.—In selecting eligible entities to receive awards under the program, the Secretary shall consider the following criteria:

(A) The potential of the technology of such eligible entity to improve domestic resilience and protect critical supply chains for critical biomanufactured products.

(B) How the technology of such eligible entity could help meet the demand for the capabilities required by the next generation of warfighters.

(C) The ability of the eligible bioindustrial manufacturing facility with respect to which such eligible entity is seeking such award to be repurposed and the range of products that such eligible bioindustrial manufacturing facility is capable of producing.

(D) Whether the eligible bioindustrial manufacturing facility with respect to which such eligible entity is seeking such award supports the goal of wide geographic distribution of bioindustrial manufacturing facility across the United States.

(E) Whether the eligible bioindustrial manufacturing facility with respect to which such eligible entity is seeking such award is located in geographic proximity to sources of input materials for the production of critical biomanufactured products or areas with established biomanfuacturing capabilities.

(F) Such additional considerations that the Secretary deems appropriate.

(4) Use of award funds.—A recipient of an award under the program may use funds received under such award for the establishment, upgrading, or retooling of one or more eligible bioindustrial manufacturing facilities to produce critical biomanufactured products, including the development of business or technical plans related to such establishment, upgrading, or retooling.

(c) Oversight.—If the Secretary establishes the program, the Secretary shall establish reporting requirements for recipients of awards under the program which shall include requirements for period reports on the following:

(1) The progress of the recipient in establishing, upgrading, or retooling the eligible bioindustrial manufacturing facility with respect to which such recipient received such award.

(2) The estimated timeline and funding requirements for the recipient to begin biomanufacturing at the eligible bioindustrial manufacturing facility described in paragraph

(1).

(3) The products, including the critical biomanufactured products, that are or will be produced at the eligible bioindustrial manufacturing facility described in paragraph

(1).

(4) The progress of the recipient in entering into an agreement with the Department of Defense or an element thereof to provide critical biomanufactured products, that are or will be produced at the eligible bioindustrial manufacturing facility described in paragraph (1) once such eligible bioindustrial manufacturing facility begins biomanufacturing.

(d) Reports to Congress.—

(1) Initial report.—Not later than 90 days after the date of the enactment of this Act, the Secretary shall submit to the Committees on Armed Services of the House of Representatives and Senate a report on the plan of the Secretary for allocating amounts appropriated to the Department of Defense to fund the program.

(2) Annual reports.—Not later than one year after the date of the enactment of this Act, and annually thereafter, the Secretary shall submit to the Committees on Armed Services of the House of Representatives and Senate a report on the activities under the program, including—

(A) a list of the awards made under the program as of the date on which the report is submitted, including, for each such award—

(i) the name of the entity that received the award;

(ii) the location of the eligible bioindustrial manufacturing facility with respect to which such entity received the award;

(iii) the amount of the award, disaggregated by the initial amount of the award and any additional amounts provided under the award;

(iv) an explanation of the criteria supporting making the award to such entity, including a description of any notable technologies of such entity relevant to the award;

(v) if applicable, an explanation of the rational for providing additional amounts under the award; and

(vi) to the extent practicable, and explanation of the effects of the award;

(B) an identification of amounts available to the Department of Defense for making awards under the program as of the date on which the report is submitted and an explanation of any plans for the use of such amounts;

(C) an explanation of the communication between the Secretary and eligible entities seeking an award under the program regarding requirements and timelines for such awards; and

(D) an explanation of how the establishment, upgrading, or retooling of the eligible bioindustrial manufacturing facility for which awards were made under the program aligns with priorities and needs of the Department of Defense and national security.

(e) Sunset.—

(1) In general.—Except as provided by paragraph (2), this section shall terminate on the date that is 10 years after the date of the enactment of this Act.

(2) Extension.—The Secretary may change the date on which this section terminates to a date that is later than the date on which this section would terminate under paragraph (1) if the President determines that the continuation of the program is necessary to meet national economic and national security needs.

(f) Definitions.—In this section:

(1) The term “biomanufacturing” means the utilization of biological systems to develop new and advance existing products, tools, and processes at commercial scale.

(2) The term “critical biomanufactured product” means a chemical, material, and other product that is manufactured using biomanufacturing and is relevant to the Department of Defense.

(3) The term “eligible bioindustrial manufacturing facility” means a bioindustrial manufacturing facility that—

(A) is or, if not yet established, will be located in the United States; and

(B) is or, pursuant to an award under the program, will produce critical biomanufactured products.

(4) The term “eligible entity” means an entity that—

(A) is a private entity;

(B) applied for an award under the program in accordance with subsection (b)(1); and

(C) meets such other criteria for eligibility for an award under the program as determined by the Secretary.

(5) The term “program” means the program established under subsection (a).

(6) The term “Secretary” means the Secretary of Defense. <all>